Abstract
Purpose
Head-up tilt test (HUTT) is a reasonable diagnostic evaluation for patients with suspected vasovagal syncope; however, its lengthy duration is a remarkable limitation. Although adenosine (AD), as an alternative provocative agent, is a promising option for tackling this shortcoming, it received little appreciation in the literature. We aimed to compare the efficacy and the time to elicit a positive response to HUTT for sublingual trinitroglycerin (TNG) and intravenous AD. Furthermore, we evaluated patients’ outcomes in the follow-up.
Methods
Patients with a chief complaint of transient loss of consciousness (TLOC) were evaluated. We randomized patients with the diagnosis of unexplained syncope after diagnostic evaluations, to undergo TNG-augmented HUTT or AD-augmented HUTT. They were crossed over to receive the other medication in case of negative response to the test. In the follow-up, we evaluated traumatic and non-traumatic TLOCs, hospitalization due to syncope, and death in patients.
Results
We randomized 132 patients (41.70 ± 19.37 years, 52.3% female) to receive TNG (n = 66) or AD (n = 66). Respectively, the positivity rate of TNG and AD for the first and the crossover-HUTT was 31.1% and 26.7%, and 20.5% and 26.2% with no statistically significant differences in both tests (P ˃ 0.50). The time to positive response was significantly shorter for AD than TNG (P < 0.001). In the follow-up, re-admission was significantly more prevalent in HUTT-negative patients compared to HUTT-positive patients (P = 0.04).
Conclusions
We found that diagnostic yield of TNG and AD in HUTT is comparable, while AD acts 4 times faster than TNG in evoking a vasovagal response.
Similar content being viewed by others
References
Lee TM, Chen MF, Su SF, Chao CL, Liau CS, Lee YT. Excessive myocardial contraction in vasovagal syncope demonstrated by echocardiography during head-up tilt test. Clin Cardiol. 1996;19(2):137–40.
Shalev Y, Gal R, Tchou PJ, Anderson AJ, Avitall B, Akhtar M, et al. Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt. J Am Coll Cardiol. 1991;18(3):746–51.
Forleo C, Guida P, Iacoviello M, Resta M, Monitillo F, Sorrentino S, et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol. 2013;168(1):27–35. https://doi.org/10.1016/j.ijcard.2012.09.023.
Fenton AM, Hammill SC, Rea RF, Low PA, Shen WK. Vasovagal syncope. Ann Intern Med. 2000;133(9):714–25. https://doi.org/10.7326/0003-4819-133-9-200011070-00014.
Layland J, Carrick D, Lee M, Oldroyd K, Berry C. Adenosine: physiology, pharmacology, and clinical applications. J Am Coll Cardiol Intv. 2014;7(6):581–91. https://doi.org/10.1016/j.jcin.2014.02.009.
Fragakis N, Antoniadis AP, Saviano M, Vassilikos V, Pappone C. The use of adenosine and adenosine triphosphate testing in the diagnosis, risk stratification and management of patients with syncope: current evidence and future perspectives. Int J Cardiol. 2015;183:267–73. https://doi.org/10.1016/j.ijcard.2015.01.089.
Carrega L, Saadjian AY, Mercier L, Zouher I, Bergé-Lefranc JL, Gerolami V, et al. Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. Heart Rhythm. 2007;4(7):870–6. https://doi.org/10.1016/j.hrthm.2007.03.002.
Deharo JC, Mechulan A, Giorgi R, Franceschi F, Prevot S, Peyrouse E, et al. Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope. Heart. 2012;98(11):855–9. https://doi.org/10.1136/heartjnl-2011-301411.
Saadjian AY, Gerolami V, Giorgi R, Mercier L, Berge-Lefranc JL, Paganelli F, et al. Head-up tilt induced syncope and adenosine A(2A) receptor gene polymorphism. Eur Heart J. 2009;30(12):1510–5. https://doi.org/10.1093/eurheartj/ehp126.
Saadjian AY, Levy S, Franceschi F, Zouher I, Paganelli F, Guieu RP. Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation. 2002;106(5):569–74.
Deharo J-C, Guieu R, Mechulan A, Peyrouse E, Kipson N, Ruf J, et al. Syncope without prodromes in patients with normal heart and normal electrocardiogram. J Am Coll Cardiol. 2013;62(12):1075. https://doi.org/10.1016/j.jacc.2013.05.060.
Guieu R, Deharo JC, Ruf J, Mottola G, Kipson N, Bruzzese L, et al. Adenosine and clinical forms of neurally-mediated syncope. J Am Coll Cardiol. 2015;66(2):204–5. https://doi.org/10.1016/j.jacc.2015.04.066.
Franceschi F, By Y, Peyrouse E, Fromonot J, Gerolami V, Kipson N, et al. A2A adenosine receptor function in patients with vasovagal syncope. Europace. 2013;15(9):1328–32. https://doi.org/10.1093/europace/eut066.
Mechulan A, Deharo JC, Giorgi R, Prevot S, Montserrat C, Peyrouse E, et al. Expression of adenosine A2A receptors and ATP-test in patients with syncope of unexplained origin. Eur Heart J. 2010;31:888–9. https://doi.org/10.1093/eurheartj/ehq290.
Poorhosseini H, Abbasi SH. The Tehran Heart Center. Eur Heart J. 2018;39(29):2695–6. https://doi.org/10.1093/eurheartj/ehy369.
Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, & Giani P. Proposed classification for vasovagal syncope. European Journal of Cardiac Pacing and Electrophysiology. 1992;2.
Brignole M, Menozzi C, Del Rosso A, Costa S, Gaggioli G, Bottoni N, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification: Analysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. Europace. 2000;2(1):66–76. https://doi.org/10.1053/eupc.1999.0064.
Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997;79(12A):2–10.
Iwamoto T, Umemura S, Toya Y, Uchibori T, Kogi K, Takagi N, et al. Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. Biochem Biophys Res Commun. 1994;199(2):905–10. https://doi.org/10.1006/bbrc.1994.1314.
Biaggioni I, Olafsson B, Robertson RM, Hollister AS, Robertson D. Cardiovascular and respiratory effects of adenosine in conscious man. Evidence for chemoreceptor activation. Circ Res. 1987;61(6):779–86.
Biaggioni I, Killian TJ, Mosqueda-Garcia R, Robertson RM, Robertson D. Adenosine increases sympathetic nerve traffic in humans. Circulation. 1991;83(5):1668–75.
Jackson EK. Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. Am J Phys. 1987;253(4 Pt 2):H909–18. https://doi.org/10.1152/ajpheart.1987.253.4.H909.
Mittal S, Stein KM, Markowitz SM, Slotwiner DJ, Rohatgi S, Lerman BB. Induction of neurally mediated syncope with adenosine. Circulation. 1999;99(10):1318–24.
Berne RM, Rubio R, Curnish RR. Release of adenosine from ischemic brain: effect on cerebral vascular resistance and incorporation into cerebral adenine nucleotides. Circ Res. 1974;35. https://doi.org/10.1161/01.res.35.2.262.
Mitro P, Habalova V, Evin L, Muller E, Simurda M, Slaba E, et al. Gene polymorphism of the adenosine A2a receptor in patients with vasovagal syncope. Pacing Clin Electrophysiol. 2016;39(4):330–7. https://doi.org/10.1111/pace.12806.
Ueeda M, Thompson RD, Arroyo LH, Olsson RA. 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. J Med Chem. 1991;34(4):1334–9.
Brignole M, Gaggioli G, Menozzi C, Del Rosso A, Costa S, Bartoletti A, et al. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope. Heart. 2000;83(1):24–8. https://doi.org/10.1136/heart.83.1.24.
Mittal S, McNulty EJ, Stein KM, Markowitz SM, Slotwiner DJ, Iwai S, et al. Clinical utility of an adenosine-nitroglycerin tilt test protocol. J Am Coll Cardiol. 2002;39(5):115A.
Farwell DJ, Sulke AN. A randomised prospective comparison of three protocols for head-up tilt testing and carotid sinus massage. Int J Cardiol. 2005;105(3):241–9. https://doi.org/10.1016/j.ijcard.2004.10.066.
Kirsch P, Mitro P, Mudrakova K, Valocik G. Diagnostic yield of adenosine and nitroglycerine stimulated tilt test in patients with unexplained syncope. Bratisl Lek Listy. 2007;108(6):259–64.
Mitro P, Kirsch P. The use of adenosine in the diagnosis of suspected vasovagal syncope. J Cardiovasc Electrophysiol. 2009;20:S85. https://doi.org/10.1111/j.1540-8167.2009.01586.x.
Mittal S, Stein KM, Markowitz SM, Iwai S, Guttigoli A, Lerman BB. Single-stage adenosine tilt testing in patients with unexplained syncope. J Cardiovasc Electrophysiol. 2004;15(6):637–40. https://doi.org/10.1046/j.1540-8167.2004.03556.x.
Shen WK, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, et al. Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol. 1996;28(1):146–54.
Watanabe N, Kawasaki S, Oonishi Y, Onuma Y, Munetsugu Y, Itou T, et al. Characteristics of head-up tilt testing with additional adenosine compared with head-up tilt testing with isoproterenol and isosorbide dinitrate. Journal of Arrhythmia. 2014;30(6):473–7. https://doi.org/10.1016/j.joa.2014.02.004.
Acknowledgments
We also acknowledge the dedicated staff of Tehran Heart Center for their invaluable supports.
Funding
This study was funded by Tehran University of Medical Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The protocol of the study conforms to the 1964 Helsinki declaration and has been approved by the ethics committee of Tehran University of Medical Sciences with the approval ID of IR.TUMS.MEDICINE.REC.1397.272.
Informed consent
We obtained written informed consents from all of the participants or their parents if their age was less than 18.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tajdini, M., Aminorroaya, A., Rahimi, B. et al. Comparison of trinitroglycerin and adenosine as provocative agents for head-up tilt test in patients with unexplained syncope: a semi-crossover randomized clinical trial with prospective follow-up. J Interv Card Electrophysiol 60, 31–39 (2021). https://doi.org/10.1007/s10840-019-00652-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-019-00652-6